UCB to Acquire Zymvol Biomarker Research, Expanding Autoimmune Disease Portfolio
UCB announces plans to acquire Zymvol Biomarker Research, a leader in antibody treatments for autoimmune diseases. The deal strengthens UCB's pipeline...
UCB announces plans to acquire Zymvol Biomarker Research, a leader in antibody treatments for autoimmune diseases. The deal strengthens UCB's pipeline...
Sanofi's research priorities are under review as new CEO Belén Garijo begins her tenure. The company's recent focus on immunology has yielded lacklust...
As NASA advances plans for a lunar base following the Artemis II mission, experts emphasize the critical need to address immunology and infectious dis...